Pablo Martínez de Salazar

Pablo Martínez studied medicine at the Universidad Autónoma de Madrid. He went on to earn his PhD with a thesis on the treatment of malaria with artemisinin-based combination therapy in a paediatric population at the University of Tübingen and the Albert Schweitzer Hospital in Gabon, and completed his specialist training in clinical microbiology and parasitology at the Vall d’Hebron Hospital in Barcelona. His experience as a clinician and researcher has been in different areas of tropical medicine—including malaria, filariasis, and helminthiasis—and in various countries, such as Gabon (Albert Schweitzer Hospital in Lambarené), Indonesia (Universitas Indonesia), Germany (Institut fûr Tropenmedizin, Eberhard Karls Universität, Tübingen) and Holland (Leiden University Medical Centre in Leiden). He has also collaborated as an investigator with the Faculty of Infectious and Tropical diseases of the London School of Hygiene and Tropical Medicine on a research project relating to Chagas disease. During the period 2014-2015—at the time of the Chikungunya virus epidemic and the start of the Zika virus epidemic—he was head of the Department of Virology and Vaccine-Preventable Diseases at the laboratory of the Caribbean Public Health Agency (CARPHA) and later Acting Director of the Laboratory Services and Networks at the same agency.